Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2024)
Top healthcare stocks in 2024 ranked by overall Zen Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Score Price Valuation Financials Forecast

Earnings & Revenue Dividends Ownership Technicals

Ticker	Company	Market Cap	Price	Price Target	Upside/Downside	Consensus	Analysts	Fore. Revenue Growth	Fore. Earnings Growth	Forecast ROE	Forecast ROA
INCY	INCYTE CORP	$11.60B	$51.68	$74.69	44.53%	Buy	13	11.26%	52.77%	N/A	N/A
HRMY	HARMONY BIOSCIENCES HOLDINGS INC	$1.66B	$29.32	$37.33	27.33%	Buy	6	17.13%	42.05%	N/A	N/A
SMLR	SEMLER SCIENTIFIC INC	$183.58M	$26.11	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
VYGR	VOYAGER THERAPEUTICS INC	$413.77M	$7.62	$20.50	169.03%	Strong Buy	4	-25.11%	N/A	N/A	N/A
INMD	INMODE LTD	$1.44B	$17.14	$27.00	57.53%	Buy	3	2.20%	N/A	N/A	N/A
NBIX	NEUROCRINE BIOSCIENCES INC	$13.53B	$135.99	$144.65	6.37%	Buy	17	15.76%	54.49%	N/A	N/A
PGNY	PROGYNY INC	$3.09B	$32.04	$47.00	46.69%	Strong Buy	4	19.15%	20.24%	N/A	N/A
AMLX	AMYLYX PHARMACEUTICALS INC	$119.30M	$1.76	$11.00	525.00%	Buy	5	-49.09%	142.34%	N/A	N/A
CCRN	CROSS COUNTRY HEALTHCARE INC	$595.20M	$17.14	$20.80	21.35%	Buy	5	-13.31%	25.69%	N/A	N/A
UTHR	UNITED THERAPEUTICS CORP	$11.00B	$233.85	$298.00	27.43%	Strong Buy	7	9.49%	8.78%	N/A	N/A
EXEL	EXELIXIS INC	$7.19B	$23.70	$27.17	14.63%	Buy	6	8.20%	55.63%	N/A	N/A
JNJ	JOHNSON & JOHNSON	$352.02B	$146.14	$176.88	21.03%	Buy	8	3.28%	-6.26%	42.89%	17.60%
GILD	GILEAD SCIENCES INC	$81.50B	$65.42	$80.75	23.43%	Buy	12	1.92%	15.64%	N/A	N/A
BMRN	BIOMARIN PHARMACEUTICAL INC	$15.36B	$80.91	$101.67	25.65%	Buy	12	11.22%	81.99%	N/A	N/A
CORT	CORCEPT THERAPEUTICS INC	$2.36B	$22.80	$39.33	72.51%	Strong Buy	3	16.94%	29.98%	N/A	N/A
OSUR	ORASURE TECHNOLOGIES INC	$392.60M	$5.32	$6.83	28.44%	Buy	3	-52.28%	N/A	N/A	N/A
SDGR	SCHRODINGER INC	$1.73B	$23.97	$38.50	60.62%	Buy	8	24.55%	51.70%	N/A	N/A
PCRX	PACIRA BIOSCIENCES INC	$1.22B	$26.33	$47.57	80.67%	Strong Buy	7	7.43%	90.49%	N/A	N/A
SIGA	SIGA TECHNOLOGIES INC	$624.90M	$8.79	N/A	N/A	N/A	N/A	36.23%	-24.21%	N/A	N/A
PBYI	PUMA BIOTECHNOLOGY INC	$242.00M	$5.02	$7.00	39.44%	Buy	1	0.26%	31.88%	N/A	N/A
KMDA	KAMADA LTD	$296.02M	$5.15	$11.00	113.59%	Buy	1	15.57%	50.54%	N/A	N/A
AMPH	AMPHASTAR PHARMACEUTICALS INC	$1.98B	$41.11	$61.50	49.60%	Buy	2	15.18%	-11.88%	N/A	N/A
CNC	CENTENE CORP	$39.49B	$74.00	$89.00	20.27%	Strong Buy	6	-1.23%	41.84%	N/A	N/A
TCMD	TACTILE SYSTEMS TECHNOLOGY INC	$337.49M	$14.30	N/A	N/A	N/A	N/A	11.61%	N/A	N/A	N/A
HALO	HALOZYME THERAPEUTICS INC	$4.89B	$38.57	$54.17	40.44%	Buy	6	15.95%	48.53%	N/A	N/A
ADUS	ADDUS HOMECARE CORP	$1.53B	$94.54	$102.60	8.53%	Buy	5	6.34%	N/A	N/A	N/A
MOH	MOLINA HEALTHCARE INC	$20.05B	$342.23	$416.71	21.76%	Buy	7	9.79%	23.41%	N/A	N/A
VMD	VIEMED HEALTHCARE INC	$322.07M	$8.31	N/A	N/A	N/A	N/A	N/A	N/A	14.29%	10.51%
RPRX	ROYALTY PHARMA PLC	$16.73B	$28.00	$46.75	66.96%	Strong Buy	4	11.31%	34.87%	N/A	N/A
HCM	HUTCHMED (CHINA) LTD	$3.16B	$18.16	$19.55	7.65%	Buy	2	4.03%	33.58%	N/A	N/A
DOCS	DOXIMITY INC	$4.44B	$23.82	$27.88	17.02%	Hold	8	10.99%	33.42%	N/A	N/A
ASTH	ASTRANA HEALTH INC	$2.04B	$36.72	$48.00	30.72%	Strong Buy	3	19.24%	N/A	N/A	N/A
CHE	CHEMED CORP	$8.47B	$560.42	$681.00	21.52%	Buy	2	6.62%	21.67%	N/A	N/A
EW	EDWARDS LIFESCIENCES CORP	$51.94B	$86.43	$91.73	6.13%	Buy	11	9.19%	26.57%	N/A	N/A
MCK	MCKESSON CORP	$71.39B	$543.30	$555.22	2.19%	Strong Buy	9	10.70%	25.95%	N/A	N/A
MDT	MEDTRONIC PLC	$105.88B	$79.74	$94.00	17.88%	Buy	5	2.70%	27.64%	N/A	N/A
TGTX	TG THERAPEUTICS INC	$2.08B	$13.47	$30.20	124.20%	Strong Buy	5	38.43%	139.09%	N/A	N/A
STAA	STAAR SURGICAL CO	$2.29B	$46.96	$44.33	-5.59%	Buy	6	11.06%	139.79%	N/A	N/A
NSYS	NORTECH SYSTEMS INC	$47.43M	$17.31	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
COLL	COLLEGIUM PHARMACEUTICAL INC	$1.16B	$36.42	$38.60	5.99%	Strong Buy	5	-0.27%	N/A	N/A	N/A
ROIV	ROIVANT SCIENCES LTD	$8.89B	$11.03	$17.11	55.13%	Strong Buy	9	77.28%	N/A	N/A	N/A
AZN	ASTRAZENECA PLC	$233.05B	$75.17	$83.50	11.08%	Strong Buy	2	6.96%	42.12%	N/A	N/A
LNTH	LANTHEUS HOLDINGS INC	$4.49B	$65.56	$96.20	46.74%	Strong Buy	5	8.54%	-17.80%	N/A	N/A
SLP	SIMULATIONS PLUS INC	$893.13M	$44.69	$51.00	14.12%	Buy	1	20.59%	35.55%	N/A	N/A
GMAB	GENMAB A	$18.60B	$28.15	$45.00	59.86%	Buy	4	21.76%	48.09%	N/A	N/A
CVS	CVS HEALTH CORP	$84.54B	$67.18	$88.60	31.88%	Strong Buy	10	4.99%	37.17%	N/A	N/A
SEM	SELECT MEDICAL HOLDINGS CORP	$3.52B	$27.41	$32.50	18.57%	Buy	2	4.14%	65.79%	N/A	N/A
HOLX	HOLOGIC INC	$17.83B	$75.98	$83.43	9.80%	Buy	7	3.88%	50.45%	N/A	N/A
DCGO	DOCGO INC	$376.06M	$3.61	$9.80	171.47%	Strong Buy	5	9.32%	315.76%	N/A	N/A
UTMD	UTAH MEDICAL PRODUCTS INC	$236.59M	$65.92	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
COR	CENCORA INC	$48.05B	$240.88	$235.00	-2.44%	Buy	4	6.28%	27.05%	N/A	N/A
HUM	HUMANA INC	$36.86B	$305.90	$403.12	31.78%	Buy	17	3.43%	57.24%	N/A	N/A
MEIP	MEI PHARMA INC	$20.32M	$3.05	$7.00	129.51%	Hold	1	-42.12%	N/A	N/A	N/A
WST	WEST PHARMACEUTICAL SERVICES INC	$26.25B	$360.43	$460.33	27.72%	Strong Buy	3	5.73%	27.97%	N/A	N/A
VEEV	VEEVA SYSTEMS INC	$32.41B	$200.91	$239.59	19.25%	Buy	17	13.93%	24.04%	N/A	N/A
SNY	SANOFI	$124.28B	$49.13	$55.00	11.95%	Hold	1	5.20%	35.94%	N/A	N/A
ICLR	ICON PLC	$25.49B	$308.31	$344.38	11.70%	Strong Buy	8	6.30%	31.77%	N/A	N/A
CAH	CARDINAL HEALTH INC	$25.10B	$103.21	$113.17	9.65%	Buy	6	4.13%	71.17%	N/A	N/A
DXCM	DEXCOM INC	$49.45B	$124.34	$150.25	20.84%	Strong Buy	8	16.02%	5.36%	N/A	N/A
PODD	INSULET CORP	$11.62B	$166.19	$224.67	35.19%	Buy	6	17.37%	14.90%	N/A	N/A
ALC	ALCON INC	$38.85B	$78.77	$92.07	16.88%	Strong Buy	9	5.99%	32.06%	N/A	N/A
MDXG	MIMEDX GROUP INC	$921.43M	$6.27	$13.00	107.34%	Strong Buy	2	11.82%	25.46%	N/A	N/A
AMN	AMN HEALTHCARE SERVICES INC	$2.16B	$57.12	$74.20	29.90%	Buy	5	-6.41%	27.89%	N/A	N/A
TALK	TALKSPACE INC	$526.98M	$3.12	$3.00	-3.85%	Hold	1	28.43%	N/A	45.55%	38.00%
LMAT	LEMAITRE VASCULAR INC	$1.46B	$65.46	$72.00	9.99%	Strong Buy	2	8.39%	9.48%	N/A	N/A
THC	TENET HEALTHCARE CORP	$9.61B	$96.13	$103.75	7.93%	Strong Buy	12	1.13%	32.93%	N/A	N/A
GMED	GLOBUS MEDICAL INC	$6.84B	$50.55	$63.00	24.63%	Buy	6	22.07%	35.47%	N/A	N/A
IRMD	IRADIMED CORP	$530.07M	$41.86	$65.00	55.28%	Strong Buy	1	11.53%	N/A	N/A	N/A
ISRG	INTUITIVE SURGICAL INC	$133.13B	$375.33	$407.80	8.65%	Strong Buy	15	13.21%	-11.57%	N/A	N/A
UNH	UNITEDHEALTH GROUP INC	$456.68B	$495.35	$567.64	14.59%	Strong Buy	14	7.06%	12.68%	39.39%	12.77%
ZBH	ZIMMER BIOMET HOLDINGS INC	$24.48B	$119.35	$133.20	11.60%	Hold	10	4.58%	22.70%	N/A	N/A
GSK	GSK PLC	$83.37B	$41.11	$46.00	11.89%	Buy	2	4.92%	34.02%	N/A	N/A
BRKR	BRUKER CORP	$11.15B	$80.97	$85.67	5.80%	Buy	6	8.94%	0.00%	N/A	N/A
ABT	ABBOTT LABORATORIES	$186.58B	$107.53	$127.67	18.73%	Strong Buy	6	5.75%	23.18%	N/A	N/A
NVS	NOVARTIS AG	$198.82B	$97.44	$115.00	18.02%	Hold	2	1.87%	2.37%	N/A	N/A
STE	STERIS PLC	$20.15B	$203.90	$245.75	20.52%	Strong Buy	4	7.08%	52.45%	N/A	N/A
PEN	PENUMBRA INC	$7.91B	$204.41	$274.71	34.39%	Strong Buy	7	17.30%	-24.53%	N/A	N/A
BNTX	BIONTECH SE	$20.73B	$87.21	$114.71	31.54%	Hold	7	-10.50%	36.84%	N/A	N/A
FONR	FONAR CORP	$109.18M	$16.27	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CI	CIGNA GROUP	$103.63B	$354.47	$375.54	5.94%	Strong Buy	13	9.55%	41.67%	N/A	N/A
KIDS	ORTHOPEDIATRICS CORP	$712.61M	$30.26	$37.17	22.83%	Buy	6	26.25%	N/A	N/A	N/A
ALGN	ALIGN TECHNOLOGY INC	$23.21B	$309.02	$337.14	9.10%	Buy	7	8.72%	51.26%	N/A	N/A
BIIB	BIOGEN INC	$30.42B	$208.90	$284.95	36.40%	Buy	20	0.65%	31.34%	N/A	N/A
VNDA	VANDA PHARMACEUTICALS INC	$265.82M	$4.62	N/A	N/A	N/A	N/A	13.15%	102.06%	N/A	N/A
BTMD	BIOTE CORP	$411.41M	$5.52	$8.39	51.96%	Strong Buy	4	13.93%	140.57%	N/A	N/A
REGN	REGENERON PHARMACEUTICALS INC	$96.94B	$883.20	$1.00k	13.73%	Buy	16	7.40%	4.84%	N/A	N/A
STRR	STAR EQUITY HOLDINGS INC	$14.26M	$0.90	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ZTS	ZOETIS INC	$72.54B	$158.42	$215.20	35.84%	Strong Buy	5	6.66%	12.79%	N/A	N/A
PRVA	PRIVIA HEALTH GROUP INC	$2.17B	$18.26	$26.78	46.65%	Strong Buy	9	9.92%	51.83%	N/A	N/A
TFX	TELEFLEX INC	$9.73B	$206.71	$260.14	25.85%	Buy	7	5.02%	35.89%	N/A	N/A
OPCH	OPTION CARE HEALTH INC	$5.15B	$29.61	$38.00	28.34%	Strong Buy	2	8.15%	-36.86%	N/A	N/A
RVTY	REVVITY INC	$12.54B	$101.51	$114.75	13.04%	Buy	8	4.79%	21.89%	N/A	N/A
PLX	PROTALIX BIOTHERAPEUTICS INC	$84.01M	$1.15	$10.00	769.57%	Buy	1	N/A	N/A	N/A	N/A
DVA	DAVITA INC	$11.71B	$133.51	$137.67	3.11%	Buy	3	3.66%	40.21%	N/A	N/A
DBVT	DBV TECHNOLOGIES SA	$131.53M	$0.68	$10.00	1,366.28%	Buy	1	166.59%	N/A	N/A	N/A
PINC	PREMIER INC	$2.51B	$20.96	$24.50	16.89%	Buy	3	1.68%	52.55%	N/A	N/A
ATR	APTARGROUP INC	$9.50B	$143.33	$155.00	8.14%	Strong Buy	2	1.86%	1.79%	N/A	N/A
QTRX	QUANTERIX CORP	$592.27M	$15.56	$32.00	105.66%	Buy	1	15.50%	N/A	N/A	N/A
SCYX	SCYNEXIS INC	$58.14M	$1.54	N/A	N/A	N/A	N/A	-15.26%	N/A	N/A	N/A
CRL	CHARLES RIVER LABORATORIES INTERNATIONAL INC	$11.76B	$229.03	$264.00	15.27%	Buy	7	5.12%	47.49%	N/A	N/A

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	682	+1.20%	+1.13%	-9.62%	-22.18%	14.88x	5.85x	-68.98%	+2.75%	+21.30%	+91.76%	Strong Buy
Diagnostics & Research	66	+0.75%	+4.09%	-5.10%	-0.74%	38.49x	4.18x	-21.75%	+6.53%	+11.20%	+10.85%	Buy
Drug Manufacturers - General	17	+0.34%	+1.38%	-4.08%	+12.78%	159.81x	6.13x	+32.60%	+7.65%	+14.35%	+16.05%	Buy
Drug Manufacturers - Specialty & Generic	90	+0.98%	+2.24%	-2.72%	-6.94%	33.92x	2.09x	+11.56%	+2.78%	+5.22%	+37.77%	Strong Buy
Healthcare Plans	12	-0.85%	-2.11%	-4.78%	+3.59%	18.86x	2.91x	+20.02%	+6.15%	+14.19%	+16.44%	Buy
Health Information Services	61	+0.87%	+0.45%	-8.40%	-24.77%	72.49x	3.38x	+6.61%	+2.33%	+5.91%	+38.22%	Buy
Medical Care Facilities	50	-0.63%	-0.25%	-6.53%	+3.06%	-1.17x	4.49x	-87.35%	+6.17%	+13.08%	+19.34%	Buy
Medical Devices	154	+0.28%	+1.14%	-4.31%	-15.96%	28.63x	3.70x	+10.75%	+5.35%	+7.78%	+22.84%	Buy
Medical Distribution	9	+0.52%	+1.70%	-0.69%	+37.51%	26.24x	147.94x	+18.14%	+3.52%	+19.64%	+3.58%	Buy
Medical Instruments & Supplies	56	+1.23%	+1.70%	-4.37%	-11.53%	48.29x	3.53x	+11.70%	+7.83%	+10.36%	+20.52%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Apr 2024?

According to Zen Score, the 3 best healthcare stocks to buy right now are:

1. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the top healthcare stock with a Zen Score of 75, which is 50 points higher than the healthcare sector average of 25. It passed 24 out of 33 due diligence checks and has strong fundamentals. Incyte has seen its stock lose -29.72% over the past year, underperforming other healthcare stocks by -20 percentage points.

Incyte has an average 1 year price target of $74.69, an upside of 44.53% from Incyte's current stock price of $51.68.

Incyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Incyte, 23.08% have issued a Strong Buy rating, 23.08% have issued a Buy, 53.85% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second best healthcare stock with a Zen Score of 70, which is 45 points higher than the healthcare sector average of 25. It passed 23 out of 33 due diligence checks and has strong fundamentals. Harmony Biosciences Holdings has seen its stock lose -7.45% over the past year, overperforming other healthcare stocks by 3 percentage points.

Harmony Biosciences Holdings has an average 1 year price target of $37.33, an upside of 27.33% from Harmony Biosciences Holdings's current stock price of $29.32.

Harmony Biosciences Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Harmony Biosciences Holdings, 33.33% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a Hold, while 16.67% have issued a Sell rating, and 16.67% have issued a Strong Sell.

3. Semler Scientific (NASDAQ:SMLR)

Semler Scientific (NASDAQ:SMLR) is the third best healthcare stock with a Zen Score of 68, which is 43 points higher than the healthcare sector average of 25. It passed 21 out of 33 due diligence checks and has strong fundamentals. Semler Scientific has seen its stock lose -0.61% over the past year, overperforming other healthcare stocks by 10 percentage points.

What are the healthcare stocks with highest dividends?

Out of 73 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Carisma Therapeutics (NASDAQ:CARM)

Carisma Therapeutics (NASDAQ:CARM) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 2.84%.

Carisma Therapeutics's dividend payout ratio of 0% indicates that its dividend yield might not be sustainable for the long-term.

2. Mei Pharma (NASDAQ:MEIP)

Mei Pharma (NASDAQ:MEIP) has an annual dividend yield of 57.38%, which is 55 percentage points higher than the healthcare sector average of 2.84%.

Mei Pharma's dividend payout ratio of 58.9% indicates that its high dividend yield is sustainable for the long-term.

3. Siga Technologies (NASDAQ:SIGA)

Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 11.95%, which is 9 percentage points higher than the healthcare sector average of 2.84%.

Siga Technologies's dividend payout ratio of 47.4% indicates that its high dividend yield is sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.62% in the last day, and up 1.39% over the last week. Biodexa Pharmaceuticals was the among the top gainers in the healthcare sector, gaining 79.31% yesterday.

Biodexa shares are trading higher after the company entered an exclusive license agreement with Rapamycin Holdings for the rights to eRapa.

What are the most undervalued healthcare stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued healthcare stocks right now are:

1. Pacira Biosciences (NASDAQ:PCRX)

Pacira Biosciences (NASDAQ:PCRX) is the most undervalued healthcare stock based on WallStreetZen's Valuation Score. Pacira Biosciences has a valuation score of 100, which is 83 points higher than the healthcare sector average of 17. It passed 7 out of 7 valuation due diligence checks.

Pacira Biosciences's stock has dropped -40.25% in the past year. It has underperformed other stocks in the healthcare sector by -30 percentage points.

2. Inmode (NASDAQ:INMD)

Inmode (NASDAQ:INMD) is the second most undervalued healthcare stock based on WallStreetZen's Valuation Score. Inmode has a valuation score of 100, which is 83 points higher than the healthcare sector average of 17. It passed 7 out of 7 valuation due diligence checks.

Inmode's stock has dropped -53.19% in the past year. It has underperformed other stocks in the healthcare sector by -43 percentage points.

3. Orasure Technologies (NASDAQ:OSUR)

Orasure Technologies (NASDAQ:OSUR) is the third most undervalued healthcare stock based on WallStreetZen's Valuation Score. Orasure Technologies has a valuation score of 100, which is 83 points higher than the healthcare sector average of 17. It passed 7 out of 7 valuation due diligence checks.

Orasure Technologies's stock has dropped -19.88% in the past year. It has underperformed other stocks in the healthcare sector by -10 percentage points.

Are healthcare stocks a good buy now?

47.57% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 39.51% over the next year.

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 74.01x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.